MALNIQUE, Fabricio et al. USE OF DAPAGLIFLOZIN (FORXIGA) IN THE MANAGEMENT OF OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES. Seven Editora, [S. l.], p. 368–379, 2025. Disponível em: https://sevenpubl.com.br/editora/article/view/8517. Acesso em: 21 nov. 2025.